Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates
Abstract
No abstract availableKeywords
Funding Information
- Universiti Kuala Lumpur
- Fundamental Research Grant Scheme (FRGS/1/2017/STG05/UNIKL/02)
This publication has 17 references indexed in Scilit:
- Ampicillin in Combination with Ceftaroline, Cefepime, or Ceftriaxone Demonstrates Equivalent Activities in a High-Inoculum Enterococcus faecalis Infection ModelAntimicrobial Agents and Chemotherapy, 2016
- Increases in plasma plant sterols stabilize within four weeks of plant sterol intake and are independent of cholesterol metabolismNutrition, Metabolism and Cardiovascular Diseases, 2016
- Strong and Nonspecific Synergistic Antibacterial Efficiency of Antibiotics Combined with Silver Nanoparticles at Very Low Concentrations Showing No Cytotoxic EffectMolecules, 2015
- Beta-Lactamase Repressor BlaI Modulates Staphylococcus aureus Cathelicidin Antimicrobial Peptide Resistance and VirulencePLOS ONE, 2015
- Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing EnterobacteriaceaeClinical Infectious Diseases, 2015
- Beta-Lactam Antibiotics Induce a Lethal Malfunctioning of the Bacterial Cell Wall Synthesis MachineryCell, 2014
- Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coliPhytomedicine, 2014
- Combination approaches to combat multidrug-resistant bacteriaTrends in Biotechnology, 2013
- The crisis of no new antibiotics—what is the way forward?The Lancet Infectious Diseases, 2012
- Outpatient antibiotic use in Europe and association with resistance: a cross-national database studyThe Lancet, 2005